13 February 2012 - Life sciences company SeraCare Life Sciences Inc (NASDAQ:SRLS) reported on Friday its net income of USD1.0m (USD0.05 per share on a basic and diluted basis) for its 2012 fiscal first quarter ended 31 December 2011.

This reflects a drop when compared with net income of U...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up